Policlinico Universitario Fondazione Agostino Gemelli - Roma
Roma, RM, 00136, Italy
NCT Number: NCT07485374
The purpose of this multicentric study was to assess the attitude of Italian dental students towards HIV-infected patients. In particular, the level of discomfort perceived during the treatment, any discriminatory attitude on their part, their level of knowledge of the disease and the application of the sterilization protocols to avoid professional exposure and cross-infections.
Trial opening soon.
Get NotifiedAll sexes
Observational
Roma, RM, 00136, Italy
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An anonymous questionnaire, accompanied by an informative letter, will be developed to this purpose, describing the aim of the study.
The questionnaire was structured into four sections.
The first section investigates personal demographic data. The second section evaluates the relationship between students and HIV-positive patients.
The third section evaluates the student's knowledge of the HIV infection and the source of his knowledge.
The fourth section investigates the application of the preventive operative protocols to avoid cross-infections
Time frame: Baseline
Students answering positively to the question "Do you think you have ever adopted a discriminatory behavior towards seropositive patients?", whenever asked to treat an HIV positive patient will be cathegorized as having a discriminatory behavior (Dichotomous variable)
Trial opening soon.
Get NotifiedFondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Acronym: HIV DENT STUD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07468695
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Nairobi, Kenya
View Trial DetailsNCT07645352
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Harare, Zimbabwe
View Trial DetailsNCT07390916
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Kigali, Rwanda
View Trial DetailsNCT07645378
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Durban, South Africa
View Trial Details